Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
139.16
+1.64 (+1.19%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,718,340
Open
138.21
Bid (Size)
138.62 (1)
Ask (Size)
139.20 (43)
Prev. Close
137.52
Today's Range
137.85 - 139.74
52wk Range
86.96 - 148.15
Shares Outstanding
N/A
Dividend Yield
1.27%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
Today 15:30 EDT
Ozempic may offer unexpected anti-aging benefits, potentially improving health and reducing mortality rates, according to new research.
Via
Benzinga
3 No-Brainer Stocks to Buy in September
Today 7:30 EDT
There's at least one key common denominator here: tremendous growth prospects.
Via
The Motley Fool
Performance
YTD
+36.28%
+36.28%
1 Month
+4.92%
+4.92%
3 Month
+2.87%
+2.87%
6 Month
+12.02%
+12.02%
1 Year
+49.94%
+49.94%
More News
Read More
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
Today 7:10 EDT
Via
The Motley Fool
Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits
August 30, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
August 30, 2024
Via
Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
August 27, 2024
Via
Benzinga
What the Options Market Tells Us About Novo Nordisk
August 22, 2024
Via
Benzinga
This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock
August 30, 2024
Via
The Motley Fool
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
August 29, 2024
Via
Investor's Business Daily
Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?
August 29, 2024
Via
The Motley Fool
Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker
August 28, 2024
Via
Benzinga
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
August 27, 2024
Via
Investor's Business Daily
Ozempic Could Have a Terrible Side Effect. Is Novo Nordisk in Trouble?
August 27, 2024
Via
The Motley Fool
Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
August 26, 2024
Via
Benzinga
Eli Lilly’s Path to the Next Trillion Market Capitalization
August 26, 2024
Via
MarketBeat
Novo Nordisk Does Not Operate As Drug Cartel, CEO Defends US Pricing Of Ozempic Against Criticism Over High Drug Prices
August 26, 2024
Via
Benzinga
This GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its Money
August 25, 2024
Via
The Motley Fool
2 No-Brainer Healthcare Stocks to Buy With $1,000
August 24, 2024
Via
The Motley Fool
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Via
Benzinga
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
August 23, 2024
Via
News Direct
These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk
August 23, 2024
Via
The Motley Fool
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
August 23, 2024
Via
The Motley Fool
Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages
August 21, 2024
Via
Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
August 21, 2024
Via
Benzinga
Topics
Economy
Exposures
Supply Chain
Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?
August 21, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.